AUA 2026: Diet and Hormone Therapy Emerging as UTI Prevention Tools for Women

Event summary

  • AUA 2026 highlights dietary patterns and hormone therapy as potential tools to reduce recurrent UTIs in women.
  • Population-based analysis of 57,000 women shows vegetarians (especially lacto-ovo-vegetarians and vegans) have lower UTI recurrence rates.
  • FDA's 2025 removal of black box warnings on certain hormone therapies supports their use in managing genitourinary syndrome of menopause (GSM).
  • AUA's updated GSM Guideline reflects evolving clinical guidance on hormone therapy for UTI prevention.

The big picture

The AUA 2026 findings reflect growing interest in non-antibiotic strategies for UTI prevention amid rising antibiotic resistance. The FDA's regulatory shift on hormone therapies signals broader industry movement toward safer, more effective GSM management. These developments could reshape treatment paradigms for recurrent UTIs, particularly in postmenopausal women.

What we're watching

Regulatory Impact
How FDA's 2025 hormone therapy guidance update will affect clinical adoption rates and patient access.
Dietary Research
Whether the observed correlation between plant-based diets and lower UTI recurrence will lead to formal dietary recommendations.
Therapeutic Shifts
The pace at which non-antibiotic prevention strategies gain traction in urological practice guidelines.